CBD 2.0

Owner

Goods & Services

Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the prevention of chemotherapy induced peripheral neuropathy, neurodegeneration, oxidative stress related diseases and disorders, neuropathic pain, and atopic dermatitis; Pharmaceutical preparations for the treatment and prevention of chemotherapy induced peripheral neuropathy, neurodegeneration, oxidative stress related diseases and disorders, neuropathic pain, and atopic dermatitis; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of chemotherapy induced peripheral neuropathy, neurodegeneration, oxidative stress related diseases and disorders, neuropathic pain, and atopic dermatitis; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical products for the treatment of joint disease; Pharmaceutical skin lotions; Dermatological pharmaceutical products; Extracts of hops for pharmaceutical purposes; Frostbite salve for pharmaceutical purposes; Phenol for pharmaceutical purposes; Plant extracts for pharmaceutical purposes